Topiramate in migraine prevention

Headache

Volumn 45, Issue SUPPL. 1, 2005, Pages

  Silberstein, Stephen D ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Migraine; Prevention; Topiramate

Indexed keywords

TOPIRAMATE;

ANOREXIA; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG APPROVAL; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FATIGUE; HEADACHE; HUMAN; MIGRAINE; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTICONVULSANTS; DOUBLE-BLIND METHOD; FRUCTOSE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; MULTICENTER STUDIES; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS;

EID: 17244362365     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.4501005.x     Document Type: Review

References (26)

1. Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 2001;41:968-975.
2. Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr. 2003;8:428-432.
3. Silberstein SD, Bhattacharaya S, Neto W, Jacobs D. Topiramate in the prevention of migraine headache: a randomized, double-blind, placebo-controlled, multiple-dose study. Presented at the 2002 European Federation of Neurological Sciences (EFNS) meeting. Vienna, Austria, October 26-29, 2002.
4. Silberstein SD, Neto W, Schmitt J, Jacobs D for the MIGR-001 Study Group. Topiramate in migraine prevention: results of a large, controlled trial. Arch Neurol. 2004 61:490-495.
5. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291:965-973.
6. Diener HC, Tfelt-Hansen P, Dahlöf C, et al., on behalf of the MIGR-003 Study Group. Topiramate in migraine prophylaxis: results from a placebo-controlled trial with propranolol as an active control. J Neurol. 2004;251:943-950.
7. Shuaib A, Ahmed F, Muratoglu M, Kochanski P. Topiramate in migraine prophylaxis: a pilot study [abstract]. Cephalalgia. 1999;19:379-380.
8. Edwards KR, Glantz MJ, Shea P, Norton JA, Cross N. A double-blind, randomized trial of topiramate versus placebo in the prophylactic treatment of migraine headache with and without aura [abstract]. Cephalalgia. 2000;20:316.
9. Potter DL, Hart DE, Calder CS, Storey JR. A double-blind, randomized, placebo-controlled, parallel study to determine the efficacy of topiramate in the prophylactic treatment of migraine [abstract]. Neurology. 2000;54:A15.
10. Young WB, Hopkins MM, Shechter AL, Silberstein SD. Topiramate: a case series study in migraine prophylaxis. Cephalalgia. 2002;22:659-663.
11. Mathew NT, Kailasam J, Fischer A. Prophylaxis of migraine with topiramate: a retrospective analysis [abstract]. Cephalalgia. 2001;21:370.
12. Freitag FG, Hulihan J, Wu S-G. Early onset of response observed for topiramate when used as a migraine prevention agent. Poster presented at the American Headache Society 46th Annual Scientific Meeting. Vancouver, British Columbia, Canada; June 10-13, 2004.
13. Dahlof C, Papadopoulos G, Jacobs D, Neto W, Wu S-C. Topiramate improves health-related quality of life when used to prevent migraine. Poster presented at the 15th Annual Migraine Trust International Symposium. London, UK; September 20-23, 2004.
14. Adelman S, Cabez MSA, Jacobs O, Neto W, Shi Y. Analysis of safety data obtained from over 1500 patients receiving topiramate for migraine prevention. Poster presented at the American Headache Society 46th Annual Scientific Meeting. Vancouver, British Columbia, Canada; June 10-13, 2004.
15. Jones MW. Topiramate safety and tolerability. Can J Neurol Sci. 1998;25:S13-S15.
16. Sachedo RC. Topiramate. Clin Pharm. 1998;34:335-346.
17. Sachedo RC, Reife RA, Lim P, Pledge G. Topiramate monotherapy for partial onset seizures. Epilepsia. 1997;38:294-300.
18. Reife R, Pledge G, and Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia. 2000;41:S66-S71.
19. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R. Differential cognitive and behavioral effects of topiramate and valproate. Neurology. 2003;60:1483-1488.
20. Silberstein SD. Control of topiramate-induced paresthesias with supplemental potassium [letter]. Headache. 2002;42:85.
21. Krauss G, Crone N. No central nervous system side effects of antiepileptic drugs. Neurol Neurosurg. 2000;1:12.
22. York DA, Singer L, Thomas S, Bray GA. Effect of topiramate on body weight and body composition of Osborne-Mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs. Nutrition. 2000;16:967-975.
23. Richard D, Ferland J, Lalonde J, et al. Influence of topiramate in the regulation of energy balance. Nutrition. 2000;16:961-966.
24. Greenwood RS. Adverse effects of antiepileptic drugs. Epilepsia. 2000;4:S42-S51.
25. Topiramate (Topamax®). Physicians' Desk Reference, 57th ed. Montvale, New Jersey: Medical Economics Co Inc; 2003:2501-2507.
26. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002;59:1011-1014.